Clinical Practice and Research in Cardio-Oncology: Finding the "Rosetta Stone" for Establishing Program Excellence in Cardio-oncology

J Cardiovasc Transl Res. 2020 Jun;13(3):495-505. doi: 10.1007/s12265-020-10010-x. Epub 2020 May 22.

Abstract

The burgeoning field of cardio-oncology (C-O) is now necessary for the delivery of excellent care for patients with cancer. Many factors have contributed to this increasing population of cancer survivors or those being treated with novel and targeted cancer therapies. There is a tremendous need to provide outstanding cardiovascular (CV) care for these patients; however, current medical literature actually provides a paucity of guidance. C-O therefore provides a novel opportunity for clinical, translational, and basic research to advance patient care. This review aims to be a primer for cardio-oncologists on how to develop a vibrant and comprehensive C-O program, use practical tools to assist in the construction of C-O services, and to proactively incorporate translational and clinical research into the training of future leaders as well as enhance clinical care.

Keywords: Cardio-oncology; Practice excellence; Program development; Translational research.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Cancer Survivors*
  • Cardiac Imaging Techniques
  • Cardiology / organization & administration*
  • Cardiotoxicity
  • Comprehensive Health Care / organization & administration*
  • Delivery of Health Care, Integrated / organization & administration*
  • Heart Diseases / chemically induced
  • Heart Diseases / diagnostic imaging*
  • Humans
  • Medical Oncology / organization & administration*
  • Neoplasms / drug therapy*
  • Predictive Value of Tests
  • Prognosis
  • Quality Indicators, Health Care / organization & administration
  • Risk Assessment
  • Risk Factors

Substances

  • Antineoplastic Agents